Develop and manufacture biotherapeutics that address significant medical needs.
Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid reimbursement for biotherapeutics, comparative effectiveness research, and FDA approval of follow-on biologics.
Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid payment for biotherapeutics, the 340B program, and the Medicare drug benefit. Public Law 111-148, the Patient Protection and Affordable Care Act  - Medicare and Medicaid reimbursement for biotherapeutics.
H.R. 4213, the American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes for the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program.
Participated in discussions with Senate Aging Comm staff on Medicare coverage/payment issues related to cancer biotherapeutics. Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare prescription drug benefit.
H.R. 4213, the American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes related to the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. Public Law 111-148, the Patient Protection and Affordable Care Act of 2009 - Implementation issues related to the authorization for comparative effectiveness research and the the Patient-Centered Outcomes Research Institute.
HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs
136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 11 - Executive Office of the President (EOP) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TARPLIN STRATEGIES LLC
975 F Street NW Suite 500, Washington, DC, 20004, US
RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families.) RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families.)
and Families and Families. and Families and Families.